Panel Discussion: Indian Regulatory Landscape

Time: 10:30 – 11:45 Hrs

Panel would discuss the following:

  • Is there a role for lower cost innovation from Asia/ India?
  • Presentation on evolving pathways and Industry’s expectations from the Indian Regulatory
  • Key development in the Indian regulatory landscape in the last few months
  • To simplify Clinical trial approval process at the center without compromising the review process
  • Various on the process of the trials being done in India. Are these unique requirements in Indian Regulatory system isolating India?


Mr. Apurva Shah, Founder and Group Managing Director, Veeda Clinical Research Pvt. Ltd., India


  • Mr. Solomon Yimam, Assistant Country Director, U.S. FDA India Office, India
  • Dr. Khalid Khan, Managing Director, Fermish Clinical Technologies Pvt. Ltd., India
  • Ms. Maggie Massam, Head of Business Development, Clinical Practices Resource Datalink (CPRD), MHRA, UK
  • Ms. Divya Chadha Manek, NIHR Clinical Research Network, UK

Global Leaders @BioAsia 2015


Subscribe to email updates

Information about current events related to BioAsia 2015

For More Info Contact -

Ms. Paridhi Gupta

+91 - 40 - 6644 6477 / 6577

Organizers Supported By

Knowledge Partner

Event Partner